Mutations in pediatric ALK+ ALCL patients with biological implication have recently been described in some genes [52], such as TP53, MDM4, JUNB, TET1, KMT2B, KMT2A, KMT2C and KMT2E. The gene discussed is TP53; the disease is anaplastic large cell lymphoma.